---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-26-013646"
form_type: "8-K"
ticker: "NRC"
cik: "0000070487"
company_name: "NRC HEALTH"
filed_at: "2026-04-28T23:59:59+00:00"
generated_at: "2026-05-15T03:24:31.889028+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# NRC Health amends exec stock awards, eliminates repurchase right; expects $9.4M Q2 expense

## Summary
- Committee amended grants to CEO Trent Green (500k shares), COO Helen Hrdy (100k), and Chief Corp Dev Officer Andrew Monich (100k) to eliminate repurchase right.
- Cash bonuses approved: ~$1.9M for Green, ~$0.5M each for Hrdy and Monich to cover estimated taxes from award changes.
- Expected Q2 2026 expense of $9.4M: ~$6.5M non-cash accelerated equity comp and ~$2.9M cash bonus expense.
- Effective tax rate impacted by non-deductibility of amounts; future period charges eliminated.

## SEC filing metadata
- accession: 0001437749-26-013646
- form_type: 8-K
- ticker: NRC
- cik: 0000070487
- company_name: NRC HEALTH
- filed_at: 2026-04-28T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/70487/000143774926013646/0001437749-26-013646-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/70487/000143774926013646/nrc20260425_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-26-013646
- JSON: https://secwatch.observer/filing/0001437749-26-013646.json
- Plain text: https://secwatch.observer/filing/0001437749-26-013646.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.